EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study

Pontus Hedberg iD, John Karlsson Valik iD, Lina Abdel-Halim, Tobias Alfvén iD, Pontus Nauclér

Clinical Infectious Diseases · 10.04.2024 · 78 (4) · 900-907

DOI: 10.1093/cid/ciad660 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.10.2023. Verfasst von Pontus Hedberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Influenza, Human, COVID-19, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, European Union's Horizon Europe Research and Innovation Program, European Union’s Horizon Europe Research and Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a controversy over the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in an era of less virulent variants and an increasing population immunity. We compared outcomes in adults attending the emergency department (ED) with an Omicron, influenza, or respiratory syncytial virus (RSV) infection.

Methods

Retrospective multicenter cohort study including adults attending the ED in 6 acute care hospitals in Stockholm County, Sweden, with an Omicron, influenza, or RSV infection during 2021–2022 and 2015–2019. During 2021–2022, patients were tested for all 3 viruses by multiplex polymerase chain reaction (PCR) testing. The primary outcome was 30-day all-cause mortality. Secondary outcomes were 90-day all-cause mortality, hospitalization, and intensive care unit (ICU) admission.

Results

A total of 6385 patients from 2021–2022 were included in the main analyses: 4833 Omicron, 1099 influenza, and 453 RSV. The 30-day mortality was 7.9% (n = 381) in the Omicron, 2.5% (n = 28) in the influenza, and 6.0% (n = 27) in the RSV cohort. Patients with Omicron had an adjusted 30-day mortality odds ratio (OR) of 2.36 (95% confidence interval [CI] 1.60–3.62) compared with influenza and 1.42 (95% CI .94–2.21) compared with RSV. Among unvaccinated Omicron patients, stronger associations were observed compared with both influenza (OR 5.51 [95% CI 3.41–9.18]) and RSV (OR 3.29 [95% CI 2.01–5.56]). Similar trends were observed for secondary outcomes. Findings were consistent in comparisons with 5709 pre-pandemic influenza 995 RSV patients.

Conclusions

In patients attending the ED, infections with Omicron were both more common and associated with more severe outcomes compared with influenza and RSV, in particular among unvaccinated patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsInfluenza, HumanCOVID-19Respiratory Syncytial Virus, HumanAdultHumansSARS-CoV-2Cohort StudiesSeasonsEmergency Service, Hospital

Stichwörter der Autor:innen

OmicronSARS-CoV-2emergency departmentinfluenzarespiratory syncytial virus

Autor:innen und Institutionen

  • Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  • Sachs' Children and Youth Hospital, Stockholm, Sweden.

ORCID-Profile: Pontus Hedberg, John Karlsson Valik, Tobias Alfvén

Förderung

  • Swedish Research Council
  • European Union's Horizon Europe Research and Innovation Program
  • European Union’s Horizon Europe Research and Innovation Program

Zitieren

APA

Hedberg, P., Karlsson Valik, J., Abdel-Halim, L., Alfvén, T., & Nauclér, P. (2024). Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study. Clinical Infectious Diseases, 78(4), 900-907. https://doi.org/10.1093/cid/ciad660

Vancouver

Hedberg P, Karlsson Valik J, Abdel-Halim L, Alfvén T, Nauclér P. Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study. Clinical Infectious Diseases. 2024;78(4):900-907. doi:10.1093/cid/ciad660

BibTeX
@article{Hedberg2024,
  author = {Hedberg, Pontus and Karlsson Valik, John and Abdel-Halim, Lina and Alfvén, Tobias and Nauclér, Pontus},
  title = {Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {4},
  pages = {900--907},
  doi = {10.1093/cid/ciad660}
}
Kostenlos starten →